- Coming SoonNext installments of the biopharma pay series coming soonEndpoints · 1mo ago↗ source
- Biopharma's top-paid CEOs of 2025: 25 making $25M+For the first time in four years, Endpoints News is raising the bar for what it means to be a top-paid CEO. The previous floor of $20 million is no longer rich enough. The biopharma ...Endpoints · 1mo ago↗ source
- Cavalry Biosciences pursues $75M Series B to test eye and muscle disorder drugsCavalry Biosciences, the first biotech out of incubator and investor Jupiter Bioventures, is working on a $75 million Series B to bring its first two drug candidates into clinical testing, CEO Pres…Endpoints · 1mo ago↗ source